Literature DB >> 9399903

Novel alleles of the chemokine-receptor gene CCR5.

M Carrington1, T Kissner, B Gerrard, S Ivanov, S J O'Brien, M Dean.   

Abstract

The CCR5 gene encodes a cell-surface chemokine-receptor molecule that serves as a coreceptor for macrophage-tropic strains of HIV-1. Mutations in this gene may alter expression or function of the protein product, thereby altering chemokine binding/signaling or HIV-1 infection of cells that normally express CCR5 protein. Indeed, homozygotes for a 32-bp deletion allele of CCR5 (CCR5-delta 32), which causes a frameshift at amino acid 185, are relatively resistant to HIV-1 infection. Here we report the identification of 16 additional mutations in the coding region of the CCR5 gene, all but 3 of which are codon altering or "nonsynonymous." Most mutations were rare (found only once or twice in the sample); five were detected exclusively among African Americans, whereas eight were observed only in Caucasians. The mutations included 11 codon-altering nonsynonymous variants, one trinucleotide deletion, one chain-termination mutant, and three synonymous mutations. The high predominance of codon-altering alleles among CCR5 mutants (14/17 [81%], including CCR5-delta 32) is consistent with an adaptive accumulation of function-altering alleles for this gene, perhaps as a consequence of historic selective pressures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399903      PMCID: PMC1716101          DOI: 10.1086/301645

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

1.  Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.

Authors:  P A Zimmerman; A Buckler-White; G Alkhatib; T Spalding; J Kubofcik; C Combadiere; D Weissman; O Cohen; A Rubbert; G Lam; M Vaccarezza; P E Kennedy; V Kumaraswami; J V Giorgi; R Detels; J Hunter; M Chopek; E A Berger; A S Fauci; T B Nutman; P M Murphy
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

Review 2.  Chemokine receptors: gateways to inflammation and infection.

Authors:  B A Premack; T J Schall
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

3.  The extent of genetic variation in the CCR5 gene.

Authors:  M A Ansari-Lari; X M Liu; M L Metzker; A R Rut; R A Gibbs
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

4.  HIV-1 infection in an individual homozygous for the CCR5 deletion allele.

Authors:  R Biti; R Ffrench; J Young; B Bennetts; G Stewart; T Liang
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

5.  Characterization of recombination in the HLA class II region.

Authors:  M Cullen; J Noble; H Erlich; K Thorpe; S Beck; W Klitz; J Trowsdale; M Carrington
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

6.  HIV-1 infection in a man homozygous for CCR5 delta 32.

Authors:  T R O'Brien; C Winkler; M Dean; J A Nelson; M Carrington; N L Michael; G C White
Journal:  Lancet       Date:  1997-04-26       Impact factor: 79.321

7.  HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group.

Authors:  I Theodorou; L Meyer; M Magierowska; C Katlama; C Rouzioux
Journal:  Lancet       Date:  1997-04-26       Impact factor: 79.321

8.  Global distribution of the CCR5 gene 32-basepair deletion.

Authors:  J J Martinson; N H Chapman; D C Rees; Y T Liu; J B Clegg
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

9.  The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

Authors:  Y Huang; W A Paxton; S M Wolinsky; A U Neumann; L Zhang; T He; S Kang; D Ceradini; Z Jin; K Yazdanbakhsh; K Kunstman; D Erickson; E Dragon; N R Landau; J Phair; D D Ho; R A Koup
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

10.  The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.

Authors:  N L Michael; G Chang; L G Louie; J R Mascola; D Dondero; D L Birx; H W Sheppard
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

View more
  34 in total

1.  High frequency of the HIV-1 protective CCR5 delta32 deletion in native Estonians.

Authors:  I Kalev; A V Mikelsaar; L Beckman; G Tasa; P Pärlist
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Neutrality tests using DNA polymorphism from multiple samples.

Authors:  Haipeng Li; Yunwu Zhang; Ya-Ping Zhang; Yun-Xin Fu
Journal:  Genetics       Date:  2003-03       Impact factor: 4.562

3.  Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.

Authors:  J C Stephens; D E Reich; D B Goldstein; H D Shin; M W Smith; M Carrington; C Winkler; G A Huttley; R Allikmets; L Schriml; B Gerrard; M Malasky; M D Ramos; S Morlot; M Tzetis; C Oddoux; F S di Giovine; G Nasioulas; D Chandler; M Aseev; M Hanson; L Kalaydjieva; D Glavac; P Gasparini; E Kanavakis; M Claustres; M Kambouris; H Ostrer; G Duff; V Baranov; H Sibul; A Metspalu; D Goldman; N Martin; D Duffy; J Schmidtke; X Estivill; S J O'Brien; M Dean
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

Review 4.  Genetic variation and HIV-associated neurologic disease.

Authors:  Satinder Dahiya; Bryan P Irish; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

5.  Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5.

Authors:  T Shioda; E E Nakayama; Y Tanaka; X Xin; H Liu; A Kawana-Tachikawa; A Kato; Y Sakai; Y Nagai; A Iwamoto
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.

Authors:  H-F Dong; K Wigmore; M N Carrington; M Dean; J A Turpin; O M Z Howard
Journal:  Genes Immun       Date:  2005-10       Impact factor: 2.676

7.  Genetic variation within the gene encoding the HIV-1 CCR5 coreceptor in two South African populations.

Authors:  Anabela C P Picton; Maria Paximadis; Caroline T Tiemessen
Journal:  Infect Genet Evol       Date:  2010-03-04       Impact factor: 3.342

8.  Structure-function studies on non-synonymous SNPs of chemokine receptor gene implicated in cardiovascular disease: a computational approach.

Authors:  A Sai Ramesh; Rao Sethumadhavan; Padma Thiagarajan
Journal:  Protein J       Date:  2013-12       Impact factor: 2.371

9.  Dual Function of Ccr5 during Langat Virus Encephalitis: Reduction in Neutrophil-Mediated Central Nervous System Inflammation and Increase in T Cell-Mediated Viral Clearance.

Authors:  Daniela Michlmayr; Susana V Bardina; Carlos A Rodriguez; Alexander G Pletnev; Jean K Lim
Journal:  J Immunol       Date:  2016-04-29       Impact factor: 5.422

Review 10.  Genome-wide scans for footprints of natural selection.

Authors:  Taras K Oleksyk; Michael W Smith; Stephen J O'Brien
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-01-12       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.